Onyx Pharmaceuticals, Inc. (ONXX) Tuesday said first-quarter loss narrowed to $33.67 million or $0.47 per share from $56.21 million or $0.88 per share in the same period last year.
Adjusted loss for the quarter was $13.7 million or $0.19 per share. On average, 17 analysts polled by Thomson Reuters expected the company to report a loss of $0.47 per share for the quarter. Analysts' estimates typically exclude special items.
Revenues totaled $145.5 million, up from $72.0 million last year. Analysts expecetd revenues of $134.36 million.
For comments and feedback: editorial@rttnews.com